Merge taps ImagineSoftware for medical billing

ImagineSoftware, which offers billing automation software and revenue management applications, agreed to provide its services to Merge, an IBM company.

Advertisement

Under the agreement, Merge ambulatory customers will be able to upgrade to Imagine’s medical billing platform, according to a news release.

“The Merge-ImagineSoftware agreement is beneficial for our ambulatory customers in radiology and other specialties, and for both companies,” Anne Le Grand, vice president of imaging at IBM Watson Health, said in the release. “Merge will focus on developing cloud-based, cognitively-enabled global imaging offerings — a growth area for our business — while ImagineSoftware remains focused on innovation in revenue cycle management and medical billing automation solutions.”

Sam Khashman, CEO of ImagineSoftware, also expressed enthusiasm about the agreement, saying, “This strategic move provides an excellent go-forward vehicle for Merge Financials and Merge Sentinel customers while adding like-minded organizations to the ImagineSoftware community we serve today.”

 

More articles on healthcare finance:

Adeptus Health files for bankruptcy
CMS’ 2018 IPPS proposed rule: 9 things to know
Vermont hospitals ordered to lower future price growth

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Download Whitepaper

The cost-saving opportunity most health systems overlook

Many hospitals and health systems scrutinize staffing, service lines, and payer contracts for savings. Fewer look at one of their largest assets: real estate.…

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.